Abstract
Control-IQ+ is an automated insulin delivery (AID) algorithm approved for people with type 1 diabetes aged 2+ years and adults aged 18+ years with type 2 diabetes. While numerous publications support improved glycaemia and quality of life for people with diabetes, this practice paper is intended to encourage uptake for healthcare professionals (HCPs) who are less familiar with AID systems. This includes recommendations for initializing settings, as well as research and practice-based approaches to optimizing glycaemia with stronger settings (e.g., strong correction factor settings). In addition to automated insulin adjustments every 5 min, Control-IQ+ delivers a large Autobolus up to once per hour, which can improve glycaemia in people who have challenges with routine bolusing. Simple bolus strategies and tips and tricks also highlight how to make Control-IQ+ easy to use for HCPs and the person with diabetes.
| Original language | English |
|---|---|
| Pages (from-to) | 3502-3514 |
| Number of pages | 13 |
| Journal | Diabetes, Obesity and Metabolism |
| Volume | 28 |
| Issue number | 5 |
| DOIs | |
| Publication status | Accepted/In press - 29 Jan 2026 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- barriers
- continuous glucose monitoring (CGM)
- insulin pump therapy
- type 1 diabetes
- type 2 diabetes
Fingerprint
Dive into the research topics of 'Rethinking control-IQ+ technology: Simple strategies for easy optimization'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver